ecteinascidin 743 has been researched along with HIV Coinfection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aldinucci, D; Borghese, C; Casagrande, N | 1 |
1 other study(ies) available for ecteinascidin 743 and HIV Coinfection
| Article | Year |
|---|---|
In classical Hodgkin lymphoma the combination of the CCR5 antagonist maraviroc with trabectedin synergizes, enhances DNA damage and decreases three-dimensional tumor-stroma heterospheroid viability.
Topics: CCR5 Receptor Antagonists; DNA Damage; HIV Infections; Hodgkin Disease; Humans; Maraviroc; Receptors, CCR5; Trabectedin | 2022 |